Nalbuphine Injection Suppliers & Bulk Manufacturers
Available Forms: Injectable (IM, IV)
Available Strengths: 10 mg/mL, 20 mg/mL
Reference Brands: Generic formulations marketed under different names
Category:
Analgesic
Nalbuphine injectable activates kappa-opioid receptors and blocks mu-opioid receptors, providing analgesia with a ceiling effect on respiratory depression. It effectively relieves moderate to severe pain, offering rapid onset, fewer respiratory risks, and suitability for opioid-sensitive patients, making it a safer option for hospital and clinical pain management.
Nalbuphine Injection is available in Injectable (IM, IV)
and strengths such as 10 mg/mL, 20 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nalbuphine Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nalbuphine Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nalbuphine injectable is approved in the US and EU for managing moderate to severe pain, particularly in hospitals. In the US, brands like Nalbuphine Hydrochloride are regulated by the FDA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the EU, approval by EMA requires comprehensive dossiers, clinical data, and pharmacovigilance plans. Due to its ceiling effect on respiratory depression, nalbuphine is favored for safe analgesia in clinical settings. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for nalbuphine injections, ensuring adherence to European and US standards for safe, effective pain management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing